Daniel Krell

663 total citations
16 papers, 369 citations indexed

About

Daniel Krell is a scholar working on Oncology, Cancer Research and Epidemiology. According to data from OpenAlex, Daniel Krell has authored 16 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Cancer Research and 5 papers in Epidemiology. Recurrent topics in Daniel Krell's work include Neuroendocrine Tumor Research Advances (5 papers), Lung Cancer Research Studies (5 papers) and Glioma Diagnosis and Treatment (4 papers). Daniel Krell is often cited by papers focused on Neuroendocrine Tumor Research Advances (5 papers), Lung Cancer Research Studies (5 papers) and Glioma Diagnosis and Treatment (4 papers). Daniel Krell collaborates with scholars based in United Kingdom, Netherlands and Italy. Daniel Krell's co-authors include Paul Mulholland, Chiara Bardella, Justin Stebbing, Jonathan Krell, Adam E. Frampton, Anna Jones, Malcolm Galloway, Ian Tomlinson, Mireia Mato Prado and Elisa Giovannetti and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Lancet Oncology.

In The Last Decade

Daniel Krell

15 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Krell United Kingdom 10 178 146 140 107 63 16 369
Laura Sánchez-Tejada Spain 9 93 0.5× 155 1.1× 162 1.2× 74 0.7× 36 0.6× 11 378
Francesca Consoli Italy 9 128 0.7× 209 1.4× 92 0.7× 34 0.3× 24 0.4× 37 367
Rika Kasajima Japan 10 126 0.7× 133 0.9× 129 0.9× 26 0.2× 41 0.7× 37 350
Francesca Garbini Italy 13 53 0.3× 151 1.0× 93 0.7× 43 0.4× 92 1.5× 26 514
A. García Spain 10 56 0.3× 183 1.3× 84 0.6× 76 0.7× 30 0.5× 22 339
Lennart Lenk Germany 12 87 0.5× 233 1.6× 151 1.1× 30 0.3× 17 0.3× 20 415
Kimberly F. Kerstann United States 5 67 0.4× 137 0.9× 174 1.2× 69 0.6× 29 0.5× 9 400
Aikaterini Parasi Greece 9 57 0.3× 76 0.5× 74 0.5× 59 0.6× 24 0.4× 13 228
Arya Mariam Roy United States 10 79 0.4× 170 1.2× 114 0.8× 18 0.2× 24 0.4× 74 355
Xiangshan Yang China 12 72 0.4× 76 0.5× 133 0.9× 32 0.3× 21 0.3× 21 295

Countries citing papers authored by Daniel Krell

Since Specialization
Citations

This map shows the geographic impact of Daniel Krell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Krell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Krell more than expected).

Fields of papers citing papers by Daniel Krell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Krell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Krell. The network helps show where Daniel Krell may publish in the future.

Co-authorship network of co-authors of Daniel Krell

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Krell. A scholar is included among the top collaborators of Daniel Krell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Krell. Daniel Krell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
3.
4.
Hayes, Aimee R., Gregory Muller, Hakim‐Moulay Dehbi, et al.. (2021). High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Improved Prognostic Stratification With the New World Health Organization 2019 Classification. Pancreas. 50(4). 516–523. 6 indexed citations
5.
Rizzo, Francesca, Teresa Marafioti, Mohid S. Khan, et al.. (2019). Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours. British Journal of Cancer. 120(3). 294–300. 29 indexed citations
6.
Krell, Daniel, et al.. (2017). Audit of CA125 Follow-Up After First-Line Therapy for Ovarian Cancer. International Journal of Gynecological Cancer. 27(6). 1118–1122. 5 indexed citations
7.
Brown, Nicholas F., Catherine McBain, Stephen Nash, et al.. (2016). Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma. PLoS ONE. 11(5). e0156369–e0156369. 47 indexed citations
8.
Frampton, Adam E., Jonathan Krell, Nigel B. Jamieson, et al.. (2015). microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis. European Journal of Cancer. 51(11). 1389–1404. 84 indexed citations
9.
Krell, Daniel, Paul Mulholland, Justin Stebbing, Ian Tomlinson, & Chiara Bardella. (2015). HOT mutation screening in human glioblastomas. Future Science OA. 1(3). 1 indexed citations
10.
Hall, Marcia, Daniel Krell, & Rob Glynne‐Jones. (2015). Single-agent capecitabine use in patients age 70 or older with colorectal cancer.. Journal of Clinical Oncology. 33(3_suppl). 764–764. 2 indexed citations
11.
Krell, Daniel, Paul Mulholland, Adam E. Frampton, et al.. (2013). IDH Mutations in Tumorigenesis and Their Potential Role As Novel Therapeutic Targets. Future Oncology. 9(12). 1923–1935. 48 indexed citations
12.
Frampton, Adam E., Jonathan Krell, Elisa Giovannetti, et al.. (2012). Defining a prognostic molecular profile for ductal adenocarcinoma of the pancreas highlights known key signaling pathways. Expert Review of Anticancer Therapy. 12(10). 1275–1278. 3 indexed citations
13.
Krell, Daniel & Justin Stebbing. (2012). Aristolochia: the malignant truth. The Lancet Oncology. 14(1). 25–26. 9 indexed citations
14.
Krell, Daniel, et al.. (2011). Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH Mutations in Glioblastoma. PLoS ONE. 6(5). e19868–e19868. 78 indexed citations
15.
Krell, Jonathan, Catherine Harper‐Wynne, David Miles, et al.. (2009). What is the evidence for rechallenging with anthracyclines or taxanes in metastatic breast cancer? A review of the data. Journal of Clinical Oncology. 27(15_suppl). 1072–1072. 10 indexed citations
16.
Krell, Daniel & Anna Jones. (2009). Impact of effective prevention and management of febrile neutropenia. British Journal of Cancer. 101(S1). S23–S26. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Sánchez-Tejada Breakdown of academic impact, for papers by Francesca Consoli Breakdown of academic impact, for papers by Rika Kasajima Breakdown of academic impact, for papers by Francesca Garbini Breakdown of academic impact, for papers by A. García Breakdown of academic impact, for papers by Lennart Lenk Breakdown of academic impact, for papers by Kimberly F. Kerstann Breakdown of academic impact, for papers by Aikaterini Parasi Breakdown of academic impact, for papers by Arya Mariam Roy Breakdown of academic impact, for papers by Xiangshan Yang
Rankless by CCL
2026